Skip to main content
Premium Trial:

Request an Annual Quote

Arizona Bans Abortions for Genetic Anomalies

Arizona Governor Doug Ducey, a Republican, signed a bill this week that prohibits abortions for fetal genetic abnormalities, the Arizona Republic reports.

Under the new law, medical providers who terminate pregnancies solely due to a genetic condition could face jail time, the Republic says, noting there are exceptions for genetic conditions that are considered lethal. It adds that the bill further prohibits state universities from providing terminations, bans the mailing of abortion-inducing drugs, and confers civil rights on fetuses. "There's immeasurable value in every single life — regardless of genetic makeup," Ducey says in a statement.

Critics of the bill argue that it is "medically unsound" and unconstitutional, according to the Republic. In a rebuttal, Arizona Democrats say the new law "is an expansive and intrusive step toward criminalizing, restricting, and regulating women, doctors, universities, and public institutions."

Other states, including Mississippi, Missouri, and North Dakota, have passed bills prohibiting the termination of pregnancies based on fetal genetic anomalies.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.